Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
ABCL

Updated 10/6/2026, 12:42 PM ET.

ABCL

AbCellera Biologics Inc.

Buy$570,442

Hayden Michael R

Director

53,613 shat $10.64Filed Aug 24, 5:21 PM ETFiling
ABCL

AbCellera Biologics Inc.

Buy$110,300

Montalbano John S.

Director

10,000 shat $11.03Filed Aug 18, 2:45 PM ETFiling
ABCL

AbCellera Biologics Inc.

Buy$383,904

Booth Andrew

Chief Financial Officer

37,200 shat $10.32Filed Aug 14, 12:04 PM ETFiling
ABCL

AbCellera Biologics Inc.

Buy$481,033

Hayden Michael R

Director

46,387 shat $10.37Filed Aug 14, 11:50 AM ETFiling

Read from public SEC filings. Not financial advice.